申请人:Schering Aktiengesellschaft
公开号:US05095129A1
公开(公告)日:1992-03-10
New 19,11.beta.-bridged steroids of the general formula I ##STR1## where R.sup.1 stands for a methyl or ethyl radical, R.sup.2 for a hydrogen or chlorine atom or a C.sub.1 -C.sub.4 -alkyl radical, B and G, which are the same or different, respectively for a hydrogen atom, a C.sub.1 -C.sub.4 -alkyl radical or, together, for a second bond between the carbon atoms 6 and 7, B and R.sup.2 together for a methylene or an ethylene group, Z for the radical of a pentagonal or hexagonal ring, which is possibly substituted and possibly unsaturated, V stands for a possibly substituted carbocyclic or heterocyclic aryl radical, the ring A for ##STR2## M and N together meaning a second bond or M a hydrogen atom and N a hydroxy group, X means an oxygen atom, two hydrogen atoms or a hydroxyimino grouping N.about.OH, R.sup.3 and D, which are the same or different, respectively a hydrogen atom, a nitrile radical or a C.sub.1 -C.sub.4 -alkyl radical or, together, a methylene or ethylene group, E a hydrogen atom or a C.sub.1 -C.sub.4 -alkyl radical, D and E together meaning a second bond between carbon atoms 1 and 2 or together a methylene group ##STR3## with R.sup.11 in the meaning of a hydrogen atom or a C.sub.1 -C.sub.8 -alkyl radical, are described as well as their pharmaceutically tolerated addition salts with acids. The new compounds possess valuable pharmacological properties.
新的19,11-β-桥联类固醇的一般公式为I,其中R.sup.1代表甲基或乙基基团,R.sup.2代表氢原子或氯原子或C.sub.1-C.sub.4-烷基基团,B和G分别代表氢原子、C.sub.1-C.sub.4-烷基基团,或者一起代表碳原子6和7之间的第二键,B和R.sup.2一起代表亚甲基或乙烯基团,Z代表可能被取代和可能不饱和的五角形或六角形环的基团,V代表可能被取代的碳环或杂环芳基团,环A代表M和N一起意味着第二键,或者M是氢原子,N是羟基,X代表氧原子、两个氢原子或羟氧亚胺基团N.about.OH,R.sup.3和D分别代表氢原子、腈基团或C.sub.1-C.sub.4-烷基基团,或者一起代表亚甲基或乙烯基团,E代表氢原子或C.sub.1-C.sub.4-烷基基团,D和E一起代表碳原子1和2之间的第二键或一起代表亚甲基基团,其中R.sup.11的含义是氢原子或C.sub.1-C.sub.8-烷基基团,以及它们与酸形成的药物耐受性加合盐。这些新化合物具有有价值的药理学性质。